generated from atomicai/getting-started
feat: Add SOP-LAB-002 for Vineland-3 assessment administration
All checks passed
AtomicAI Tutorial Assistant / claude-assistant (pull_request) Has been skipped
All checks passed
AtomicAI Tutorial Assistant / claude-assistant (pull_request) Has been skipped
Create comprehensive standard operating procedure for administering Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) to pediatric participants with neurodevelopmental disorders. Key sections include: - Comprehensive training and competency requirements - Detailed interview and rating form administration procedures - Basal and ceiling rules for efficient assessment - Pediatric and neurodevelopmental-specific considerations - Quality control and data integrity measures - Regulatory compliance (FDA 21 CFR Part 11, GCP, HIPAA) - Deviation management and adverse event handling Addresses Change Request #3
This commit is contained in:
291
SOPs/Lab/SOP-LAB-002-Vineland-3-Assessment.md
Normal file
291
SOPs/Lab/SOP-LAB-002-Vineland-3-Assessment.md
Normal file
@@ -0,0 +1,291 @@
|
||||
---
|
||||
title: "Standard Operating Procedure for Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) Administration"
|
||||
author: ""
|
||||
date: 2025-12-29
|
||||
version: "1.0"
|
||||
status: "Draft"
|
||||
---
|
||||
|
||||
## 1. Purpose
|
||||
The purpose of this Standard Operating Procedure (SOP) is to establish standardized procedures for administering the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) to pediatric participants with neurodevelopmental disorders in research settings. This SOP ensures consistency, reliability, validity, data integrity, and regulatory compliance across all study personnel.
|
||||
|
||||
## 2. Scope
|
||||
This SOP applies to:
|
||||
- Clinical Research Coordinators (CRCs)
|
||||
- Licensed psychologists and psychometrists
|
||||
- Trained research assistants conducting Vineland-3 assessments
|
||||
- Study personnel involved in neurodevelopmental disorder research
|
||||
|
||||
This SOP covers:
|
||||
- Pre-assessment preparation and participant screening
|
||||
- Interview format selection and administration
|
||||
- Respondent selection and informed consent
|
||||
- Data collection and scoring procedures
|
||||
- Quality control and data integrity
|
||||
- Documentation and deviation handling
|
||||
|
||||
## 3. Regulatory and Quality References
|
||||
- FDA 21 CFR Part 11 – Electronic Records; Electronic Signatures
|
||||
- FDA 21 CFR Parts 50, 56, 312 – Human Subjects Protection and Clinical Investigations
|
||||
- ICH E6(R2) Good Clinical Practice (GCP)
|
||||
- ISO 9001 – Quality Management Systems
|
||||
- Vineland-3 Manual and Technical Documentation (Pearson)
|
||||
- Study Protocol and Statistical Analysis Plan
|
||||
- Institutional Review Board (IRB) Approval Letter
|
||||
- HIPAA Privacy Rule (45 CFR Part 164)
|
||||
|
||||
## 4. Definitions
|
||||
| Term | Definition |
|
||||
|-----|------------|
|
||||
| Vineland-3 | Vineland Adaptive Behavior Scales, Third Edition – a standardized assessment measuring adaptive behavior across four domains |
|
||||
| Adaptive Behavior | Skills needed for everyday living including communication, socialization, daily living, and motor skills |
|
||||
| Respondent | The person (typically parent/caregiver) who provides information about the participant's adaptive behavior |
|
||||
| Interview Form | Semi-structured format where the examiner asks questions directly to the respondent |
|
||||
| Parent/Caregiver Form | Self-administered questionnaire completed by the respondent |
|
||||
| Domain | Major category of adaptive behavior (Communication, Daily Living Skills, Socialization, Motor Skills) |
|
||||
| Standard Score | Normalized score with mean of 100 and standard deviation of 15 |
|
||||
| v-scale score | Domain and subdomain scores with mean of 15 and standard deviation of 3 |
|
||||
| Neurodevelopmental Disorder | Conditions affecting neurological development (e.g., autism spectrum disorder, ADHD, intellectual disability, genetic syndromes) |
|
||||
|
||||
## 5. Roles and Responsibilities
|
||||
| Role | Responsibility |
|
||||
|-----|----------------|
|
||||
| Principal Investigator (PI) | Overall study oversight, protocol compliance, and data integrity |
|
||||
| Licensed Psychologist | Clinical supervision, quality assurance of assessments, certification of administrators |
|
||||
| Clinical Research Coordinator | Scheduling, respondent identification, consent verification, assessment administration (if trained) |
|
||||
| Trained Research Assistant | Vineland-3 administration, accurate scoring, and documentation |
|
||||
| Data Manager | Data entry verification, database integrity, and audit compliance |
|
||||
| Quality Assurance | SOP compliance monitoring and CAPA implementation |
|
||||
|
||||
## 6. Required Training and Competency
|
||||
All personnel administering the Vineland-3 must complete:
|
||||
- Current GCP training certification
|
||||
- Vineland-3 administration training (minimum 4 hours) including:
|
||||
- Review of Vineland-3 manual and technical documentation
|
||||
- Understanding of adaptive behavior constructs
|
||||
- Practice administrations with supervision
|
||||
- Competency verification (minimum 3 supervised administrations with 95% scoring accuracy)
|
||||
- Study-specific protocol training
|
||||
- Training on this SOP with documented acknowledgment
|
||||
- HIPAA and human subjects protection training
|
||||
|
||||
*Training records and competency documentation must be maintained in the study regulatory binder and personnel files.*
|
||||
|
||||
## 7. Materials and Equipment
|
||||
- Vineland-3 Interview Form protocol booklets (age-appropriate)
|
||||
- Vineland-3 Parent/Caregiver Rating Form (if applicable)
|
||||
- Vineland-3 Scoring and Reporting Software (Q-global or equivalent)
|
||||
- Secure computer with appropriate licenses and network access
|
||||
- Participant study folder with protocol-specific forms
|
||||
- Informed consent and assent documentation
|
||||
- Private, quiet assessment room
|
||||
- Age-appropriate comfort items (toys, snacks as permitted by protocol)
|
||||
- Study-specific case report forms (CRFs)
|
||||
|
||||
## 8. Pre-Assessment Procedures
|
||||
|
||||
### 8.1 Participant Eligibility Verification
|
||||
- Confirm participant enrollment and eligibility per study protocol
|
||||
- Verify informed consent and assent (if applicable) is current and complete
|
||||
- Confirm inclusion/exclusion criteria including neurodevelopmental disorder diagnosis
|
||||
- Review participant demographics and relevant medical/developmental history
|
||||
|
||||
### 8.2 Respondent Selection
|
||||
The Vineland-3 respondent must:
|
||||
- Be the parent, primary caregiver, or individual with extensive knowledge of the participant's daily functioning
|
||||
- Have regular contact with the participant (minimum 4-6 hours per day or equivalent)
|
||||
- Be able to provide informed responses in English or approved translated version
|
||||
- Provide consent for participation in the assessment process
|
||||
|
||||
**Documentation Required**: Record respondent name, relationship to participant, and frequency of contact in study records.
|
||||
|
||||
### 8.3 Scheduling and Environment Preparation
|
||||
- Schedule assessment at a time convenient for respondent (typically 30-60 minutes)
|
||||
- Ensure private, quiet room free from distractions
|
||||
- Prepare all materials and verify software access before respondent arrival
|
||||
- Review participant's protocol schedule to coordinate with other study visits
|
||||
- Confirm respondent understanding of assessment purpose and process
|
||||
|
||||
### 8.4 Form Selection
|
||||
Select appropriate Vineland-3 form based on:
|
||||
- **Interview Form** (Comprehensive or Brief): Recommended for standardization, rapport building, and when detailed clinical information is needed
|
||||
- **Parent/Caregiver Rating Form**: Acceptable when interview format is not feasible; requires literate respondent
|
||||
- **Age Range**: Birth through 90 years (use age-appropriate norms)
|
||||
- **Protocol Requirements**: Follow study-specific form designation if specified
|
||||
|
||||
## 9. Vineland-3 Administration Procedures
|
||||
|
||||
### 9.1 General Assessment Guidelines
|
||||
- Create a comfortable, non-judgmental atmosphere
|
||||
- Explain that assessment measures typical performance, not maximum capability
|
||||
- Emphasize there are no "right" or "wrong" answers
|
||||
- Clarify that assessment focuses on what the child **usually does**, not what they **can do**
|
||||
- Maintain professional boundaries and avoid providing clinical feedback during administration
|
||||
|
||||
### 9.2 Interview Form Administration (Step-by-Step)
|
||||
|
||||
#### Starting the Interview
|
||||
1. Greet respondent and verify participant identity using two identifiers
|
||||
2. Review informed consent and confirm respondent's voluntary participation
|
||||
3. Explain assessment purpose: "This questionnaire helps us understand [participant's name]'s everyday skills in areas like communication, daily living, socializing, and movement."
|
||||
4. Establish rapport and clarify confidentiality protections
|
||||
5. Record assessment start time
|
||||
|
||||
#### Conducting the Interview
|
||||
1. **Follow Standardized Script**: Use questions as written in the Interview Form manual
|
||||
2. **Score Response in Real-Time**:
|
||||
- **2 = Yes, usually**: Performs activity habitually without reminders
|
||||
- **1 = Sometimes or partially**: Emerging skill or requires assistance
|
||||
- **0 = No, never**: Does not perform activity
|
||||
- **DK = Don't Know**: Respondent lacks sufficient information
|
||||
- **N/O = No Opportunity**: Participant has not had chance to perform activity
|
||||
3. **Probe When Necessary**: If response is unclear, ask neutral follow-up questions (e.g., "Can you give me an example of how [name] does this?")
|
||||
4. **Maintain Engagement**: Acknowledge respondent input, remain neutral, avoid leading questions
|
||||
5. **Observe for Respondent Fatigue**: Offer breaks if needed, especially with comprehensive form
|
||||
|
||||
#### Completing the Interview
|
||||
1. Administer all required items per basal/ceiling rules (see Section 9.4)
|
||||
2. Review for any skipped or ambiguous items
|
||||
3. Thank respondent for their time and participation
|
||||
4. Record assessment completion time
|
||||
5. Do **not** provide preliminary scores or clinical interpretations to respondent
|
||||
|
||||
### 9.3 Parent/Caregiver Rating Form Administration
|
||||
If using the self-administered form:
|
||||
1. Provide respondent with form and clear instructions
|
||||
2. Remain available to answer procedural questions without influencing responses
|
||||
3. Ensure private space for completion
|
||||
4. Review completed form for missing or double-marked items before respondent leaves
|
||||
5. Collect form and verify all sections are complete
|
||||
|
||||
### 9.4 Basal and Ceiling Rules (Interview Form)
|
||||
To ensure efficient and valid administration:
|
||||
|
||||
**Basal Rule**:
|
||||
- Establish a basal by obtaining **7 consecutive scores of 2**
|
||||
- If basal is not achieved, continue backward until 7 consecutive 2s are obtained
|
||||
- Items below basal are assumed to be scored as 2
|
||||
|
||||
**Ceiling Rule**:
|
||||
- Discontinue subdomain when **7 consecutive scores of 0** are obtained
|
||||
- Items above ceiling are assumed to be scored as 0
|
||||
|
||||
**Note**: Some subdomains (e.g., Motor Skills for older children) may have abbreviated ranges. Follow manual guidelines for age-specific starting points.
|
||||
|
||||
### 9.5 Pediatric and Neurodevelopmental Considerations
|
||||
When assessing children with neurodevelopmental disorders:
|
||||
- **Use Concrete Examples**: Some respondents may need help understanding items; provide neutral examples without suggesting answers
|
||||
- **Consider Adaptive Equipment**: Score based on how the child performs the activity, even with assistive devices (e.g., communication device for verbal communication items)
|
||||
- **Account for Behavioral Variability**: If behavior fluctuates significantly, ask respondent to consider typical frequency over the past month
|
||||
- **Cultural Sensitivity**: Be aware of cultural differences in expectations for adaptive behavior (e.g., self-care, socialization norms)
|
||||
- **Document Unique Circumstances**: Note in study records if participant has unusual living situation or support that affects adaptive behavior assessment
|
||||
|
||||
## 10. Scoring and Data Entry
|
||||
|
||||
### 10.1 Scoring Procedures
|
||||
- Score assessment immediately after administration while details are fresh
|
||||
- Use Vineland-3 Scoring Software (Q-global or equivalent) per licensing agreement
|
||||
- Enter all item responses accurately
|
||||
- Verify that software calculates:
|
||||
- Subdomain v-scale scores
|
||||
- Domain standard scores
|
||||
- Adaptive Behavior Composite (ABC) score
|
||||
- Percentile ranks and age equivalents (if required by protocol)
|
||||
- **Double-Check Entry**: Review for data entry errors before finalizing
|
||||
|
||||
### 10.2 Quality Control
|
||||
- **Independent Review**: Have a second trained team member verify scoring accuracy for first 10 assessments and randomly thereafter (minimum 10% of all assessments)
|
||||
- **Reconcile Discrepancies**: Resolve scoring differences through consensus review; escalate to licensed psychologist if needed
|
||||
- **Flag Unusual Patterns**:
|
||||
- Excessive "DK" or "N/O" responses (may indicate inadequate respondent)
|
||||
- Inconsistent item patterns within subdomains
|
||||
- Scores significantly discrepant from other clinical data
|
||||
- Document quality control reviews in study files
|
||||
|
||||
### 10.3 Data Entry into Study Database
|
||||
- Transfer scores to electronic Case Report Form (eCRF) per protocol schedule
|
||||
- Ensure compliance with FDA 21 CFR Part 11 for electronic data:
|
||||
- Use unique user credentials (no shared logins)
|
||||
- Document audit trail for all entries and changes
|
||||
- Maintain data backup and security protocols
|
||||
- Enter only de-identified data per HIPAA requirements
|
||||
- Verify data accuracy before database lock
|
||||
|
||||
## 11. Documentation Requirements
|
||||
All assessments must include documentation of:
|
||||
- Date and time of assessment
|
||||
- Respondent name and relationship to participant
|
||||
- Form type and version used (Interview or Parent/Caregiver)
|
||||
- Raw scores, v-scale scores, standard scores, and ABC
|
||||
- Any deviations from standard administration (see Section 12)
|
||||
- Administrator name and signature
|
||||
- Quality control review (if performed)
|
||||
- Adverse events or participant distress (if applicable)
|
||||
|
||||
**Storage**: Maintain source documentation in participant study binder. Electronic scores in secure database with access controls.
|
||||
|
||||
## 12. Deviations and Noncompliance
|
||||
|
||||
### 12.1 Common Deviations
|
||||
Examples of protocol deviations include:
|
||||
- Using unqualified or inadequately trained respondent
|
||||
- Administering assessment outside protocol-specified visit window
|
||||
- Incomplete assessment (e.g., respondent unable to complete interview)
|
||||
- Software malfunction or scoring errors
|
||||
- Loss of data due to technical issues
|
||||
|
||||
### 12.2 Deviation Management
|
||||
- **Document Immediately**: Record deviation in study deviation log and source documents
|
||||
- **Notify PI**: Report deviation per study procedures (typically within 24-48 hours)
|
||||
- **Assess Impact**: Determine if deviation affects data validity or participant safety
|
||||
- **Implement Corrective Action**: Retrain personnel, revise procedures, or exclude data as appropriate
|
||||
- **Submit Reports**: Follow institutional and sponsor requirements for deviation reporting
|
||||
|
||||
### 12.3 Handling Incomplete Assessments
|
||||
If assessment cannot be completed:
|
||||
- Document reason (e.g., respondent time constraints, participant distress, technical issue)
|
||||
- Attempt to reschedule if within protocol visit window
|
||||
- Consult PI regarding data handling (e.g., partial data use, exclusion from analysis)
|
||||
- Do not impute or estimate missing responses
|
||||
|
||||
## 13. Adverse Events and Participant Welfare
|
||||
|
||||
### 13.1 Potential Assessment-Related Issues
|
||||
While rare, be prepared for:
|
||||
- **Respondent Emotional Distress**: Questions about child's limitations may be upsetting; offer breaks, provide supportive (non-clinical) listening, refer to PI if needed
|
||||
- **Disclosure of Safety Concerns**: If respondent reveals abuse, neglect, or imminent harm, follow mandatory reporting laws and study safety protocols
|
||||
- **Participant Behavioral Issues**: If child becomes distressed during assessment, pause or discontinue; notify PI
|
||||
|
||||
### 13.2 Documentation and Reporting
|
||||
- Document any adverse event or safety concern in study safety database
|
||||
- Notify PI immediately for any serious concerns
|
||||
- Maintain participant confidentiality per HIPAA while ensuring safety
|
||||
|
||||
## 14. Data Security and Confidentiality
|
||||
- Store all paper Vineland-3 forms in locked, limited-access cabinets
|
||||
- Maintain electronic data on password-protected, encrypted systems
|
||||
- Use only study-assigned participant IDs (no PHI in assessment records)
|
||||
- Dispose of outdated or superseded records per institutional data retention policy
|
||||
- Limit access to assessment data to authorized study personnel only
|
||||
|
||||
## 15. Quality Control and Auditing
|
||||
- **Inter-Rater Reliability**: Conduct periodic reliability assessments between administrators (target ≥90% agreement)
|
||||
- **Periodic Record Review**: Quality Assurance team reviews random sample of assessments quarterly
|
||||
- **Corrective and Preventive Actions (CAPA)**: Implement when systematic issues are identified
|
||||
- **Audit Readiness**: Maintain organized, complete documentation for regulatory inspections
|
||||
|
||||
## 16. Revision History and Change Management
|
||||
All changes to this SOP must follow document control procedures per organizational SOP-001 (or equivalent). Superseded versions must be archived with documented rationale for changes.
|
||||
|
||||
## Version Control
|
||||
| Version | Date | Description of Change | Author |
|
||||
|--------|------|----------------------|--------|
|
||||
| 1.0 | 2025-12-29 | Initial Draft | "" |
|
||||
|
||||
## Approval Signatures
|
||||
| Name | Title | Signature | Date |
|
||||
|-----|-------|-----------|------|
|
||||
| "" | Principal Investigator | "" | "" |
|
||||
| "" | Licensed Psychologist | "" | "" |
|
||||
| "" | Quality Assurance | "" | "" |
|
||||
| "" | Study Sponsor Representative | "" | "" |
|
||||
Reference in New Lab Ticket
Block a user